Images List Premium Download Classic

Infectious

Infectious-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Diazabicyclooctane compounds
April 12, 2018 - N°20180099965

Or a stereoisomer, tautomer or pharmaceutically acceptable salt or ester thereof, wherein a, r1 and r2 are defined herein. Also described are pharmaceutically acceptable compositions of formula (ii) compounds as well as methods for utilizing the compounds of formula (ii) and the pharmaceutically acceptable compositions of formula (ii) compounds as antibacterial agents and β-lactamase inhibitors, useful in the ...
Vaccine compositions and methods of use thereof
University Of Miami
April 12, 2018 - N°20180099032

Nanoparticle-based vaccines, compositions, kits and methods are used for the effective delivery of one or more antigens in vivo for vaccination and antibody (e. G., monoclonal antibody) production, and for the effective delivery of peptides, proteins, sirna, rna or dna to papcs or mhc class ii positive cells (e. G. Tumor cells). Antigens may be, for example, dna that results ...
Treatment of infectious diseases
Children's Medical Center Corporation
April 12, 2018 - N°20180098972

Disclosed herein are methods for treating or preventing a disease comprising administering a pharmaceutical composition comprising a therapeutically-effective amount of nitazoxanide to a subject having the disease, wherein the disease is causally linked to infection by one or more pathogens selected from the group consisting of members of the genus ebolavirus, members of the genus marburgvirus, members of the species ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Engineered opsonin for pathogen detection and treatment
President And Fellows Of Harvard College
April 05, 2018 - N°20180094035

The present invention provides for engineered molecular opsonins that may be used to bind biological pathogens or identify subclasses or specific pathogen species for use in devices and systems for treatment and diagnosis of patients with infectious diseases, blood-borne infections or sepsis. An aspect of the invention provides for mannose-binding lectin (mbl), which is an abundant natural serum protein that ...
Targeted apheresis using binding agents or ligands immobilized on membranes
April 05, 2018 - N°20180093032

This invention teaches a method of targeted apheresis that can be used to treat a variety of different diseases including infectious diseases, autoimmune disorders, and reducing circulating biomarkers associated with certain disorders e. G. Pre-eclampsia. This invention discloses the use of apheresis membranes as the support matrix upon which one or more different binding agents (e. G. Antibodies, aptamers, binding ...
Oral delivery system
April 05, 2018 - N°20180092813

The present invention provides a delivery system for the treatment and/or prevention of infectious pathological changes, including compositions comprising polyhexanide, various pharmaceutical formulations, and processes for using these formulations in oral treatment modalities.
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Antibody molecules to lag-3 and uses thereof
Immutep S.a.
March 29, 2018 - N°20180086830

Antibody molecules that specifically bind to lag-3 are disclosed. The anti-lag-3 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious disorders.
Immunomodulators
Bristol-myers Squibb Company
March 29, 2018 - N°20180086793

The present disclosure provides compounds which are immunomodulators and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Ebna1 inhibitors and their method of use
The Wistar Institute Of Anatomy And Biology
March 29, 2018 - N°20180086699

Pharmaceutical compositions of the invention comprise ebna1 inhibitors useful for the treatment of diseases caused by ebna1 activity such as cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis. Pharmaceutical compositions of the invention also comprise ebna1 inhibitors useful for the treatment of diseases caused by latent epstein-barr virus (ebv) infection. Pharmaceutical compositions of the ...
Anti-human vista antibodies and use thereof
Janssen Pharmaceuticals, Inc.
March 22, 2018 - N°20180079811

The invention provides antagonistic and agonistic anti-human vista antibodies and antibody fragments. These antagonist antibodies and antibody fragments may be used to inhibit or block vista's suppressive effects on t cell immunity and thereby promote t cell immunity. These agonist antibodies and antibody fragments may be used to potentiate or enhance or mimic vista's suppressive effects on t cell immunity ...
Substituted urea depsipeptide analogs as activators of the clpp endopeptidase
St. Jude Children's Research Hospital
March 22, 2018 - N°20180079784

In one aspect, the invention relates to substituted urea depsipeptide analogs, derivatives thereof, and related compounds, which are useful as activators with the clpp endopeptidease; synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating infectious disease using the compounds and compositions. This abstract is intended as a scanning tool for purposes of search in ...
Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application ...
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.
March 22, 2018 - N°20180079770

The present invention relates to a novel compound of 4′-thionucleoside, a preparation method therefor, a pharmaceutical composition comprising the same and an application thereof. Specifically, the present invention relates to a phosphamide derivative of 4′-thionucleoside, a preparation method therefor, a pharmaceutical composition comprising the same, a use thereof in the preparation of a medicine for preventing or treating ...
Bacterial topoisomerase i inhibitors with antibacterial activity
University Of Hawaii
March 22, 2018 - N°20180079757

The present invention provides compounds as bacterial topoisomerase inhibitors with antibacterial activity. The present invention also provides pharmaceutical compositions comprising at least one of the compounds and methods of using the compounds and pharmaceutical compositions as antibacterial agents for treating infectious diseases.
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pd-1 peptide inhibitors
Leidos, Inc.
March 15, 2018 - N°20180071385

This disclosure provides peptides which have a strong affinity for the checkpoint receptor “programmed death 1” (pd-1). These peptides block the interaction of pd-1 with its ligand pd-l1 and can therefore be used for various therapeutic purposes, such as inhibiting the progression of a hyperproliferative disorder, including cancer, treating infectious diseases, enhancing a response to vaccination, and ...
Ibv strains and uses thereof
Biomune Company
March 08, 2018 - N°20180066236

The present invention relates to novel infectious bronchitis virus strains and the uses thereof. The invention particularly relates to an inactivated or attenuated ibv, as well as to vaccine compositions comprising the same and the uses thereof to vaccinate avians. The invention also relates to nucleic acids, infected cells and methods for detecting the infectious bronchitis virus strains of the ...
Anti-tigit antibodies
Merck Sharp & Dohme Corp.
March 08, 2018 - N°20180066055

The present invention relates to anti-tigit antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Macrolides with modified desosamine sugars and uses thereof
President And Fellows Of Harvard College
March 08, 2018 - N°20180066008

Provided herein are macrolide compounds of formula (i) and (i-n) for the treatment of infectious diseases and inflammatory conditions. The 14-membered ketolides and 14-, 15-, and 16-membered azaketolides described herein comprise modified sugars which are desosamine or mycaminose analogs. Pharmaceutical compositions and methods of treating infection diseases and inflammatory conditions using the inventive macrolides are also provided. This disclosure additionally ...
Immune checkpoint inhibitors, compositions and methods thereof
March 08, 2018 - N°20180065917

For formula (i) compounds r1, r2, x1, y1 and n are as defined in the specification. The inventive formula (i) compounds are inhibitors of the pd-1/pd-l1 protein/protein binding or functional interaction and find utility in any number of therapeutic applications, including but not limited to treatment of proliferative disorders such as cancer and infectious diseases.
Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom
Zoetis Services Llc
March 08, 2018 - N°20180064804

The present invention is directed to novel nucleotide and amino acid sequences of porcine epidemic diarrhea virus (“pedv”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine ...
Composition for treatment or prevention of infectious inflammatory diseases, or composition for immune enhancement, comprising ...
March 08, 2018 - N°20180064790

The composition of the present invention can be effectively used for preventing or treating diseases of humans and animals caused by infection from bacteria, viruses or fungi and the like by inhibiting infections such as bacterial, viral, and fungal infections at an early stage particularly through activating innate immune response.
Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious ...
Life Technologies Corporation
March 01, 2018 - N°20180060481

A method is provided in various embodiments for determining a profile data set for a subject with infectious disease or inflammatory conditions related to infectious disease based on a sample from the subject, wherein the sample provides a source of rnas. The method includes using amplification for measuring the amount of rna corresponding to at least 2 constituents from table 1. The ...
Loading